Perspective Therapeutics Statistics
Total Valuation
CATX has a market cap or net worth of $155.37 million. The enterprise value is -$15.46 million.
Important Dates
The last earnings date was Monday, November 10, 2025, after market close.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CATX has 74.34 million shares outstanding. The number of shares has increased by 35.71% in one year.
| Current Share Class | 74.34M |
| Shares Outstanding | 74.34M |
| Shares Change (YoY) | +35.71% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 0.89% |
| Owned by Institutions (%) | 53.70% |
| Float | 62.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 141.80 |
| Forward PS | 254.68 |
| PB Ratio | 0.64 |
| P/TBV Ratio | 0.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.66, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.66 |
| Quick Ratio | 8.45 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -395.93 |
Financial Efficiency
Return on equity (ROE) is -37.26% and return on invested capital (ROIC) is -20.45%.
| Return on Equity (ROE) | -37.26% |
| Return on Assets (ROA) | -17.24% |
| Return on Invested Capital (ROIC) | -20.45% |
| Return on Capital Employed (ROCE) | -34.51% |
| Revenue Per Employee | $7,679 |
| Profits Per Employee | -$755,714 |
| Employee Count | 140 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.13% in the last 52 weeks. The beta is 1.22, so CATX's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | -66.13% |
| 50-Day Moving Average | 3.12 |
| 200-Day Moving Average | 3.05 |
| Relative Strength Index (RSI) | 32.53 |
| Average Volume (20 Days) | 1,964,277 |
Short Selling Information
The latest short interest is 6.58 million, so 8.86% of the outstanding shares have been sold short.
| Short Interest | 6.58M |
| Short Previous Month | 6.78M |
| Short % of Shares Out | 8.86% |
| Short % of Float | 10.62% |
| Short Ratio (days to cover) | 4.22 |
Income Statement
In the last 12 months, CATX had revenue of $1.08 million and -$105.80 million in losses. Loss per share was -$1.45.
| Revenue | 1.08M |
| Gross Profit | -60.89M |
| Operating Income | -94.63M |
| Pretax Income | -108.41M |
| Net Income | -105.80M |
| EBITDA | -91.69M |
| EBIT | -94.63M |
| Loss Per Share | -$1.45 |
Full Income StatementBalance Sheet
The company has $174.14 million in cash and $3.31 million in debt, giving a net cash position of $170.82 million or $2.30 per share.
| Cash & Cash Equivalents | 174.14M |
| Total Debt | 3.31M |
| Net Cash | 170.82M |
| Net Cash Per Share | $2.30 |
| Equity (Book Value) | 242.22M |
| Book Value Per Share | 3.26 |
| Working Capital | 157.88M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$84.43 million and capital expenditures -$22.29 million, giving a free cash flow of -$106.72 million.
| Operating Cash Flow | -84.43M |
| Capital Expenditures | -22.29M |
| Free Cash Flow | -106.72M |
| FCF Per Share | -$1.44 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -8,802.51% |
| Pretax Margin | -10,084.74% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CATX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -35.71% |
| Shareholder Yield | -35.71% |
| Earnings Yield | -68.10% |
| FCF Yield | -68.69% |
Analyst Forecast
The average price target for CATX is $11.73, which is 461.24% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.73 |
| Price Target Difference | 461.24% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 169.70% |
| EPS Growth Forecast (5Y) | -3.11% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 17, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jun 17, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
CATX has an Altman Z-Score of 1.69 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.69 |
| Piotroski F-Score | 2 |
